OOIR: Observatory of International Research

Papers

(The TQCC of American Journal of Clinical Oncology-Cancer Clinical Trials is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
The Impact of the COVID-19 Pandemic on Cancer Patients	248
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors	132
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody	35
The Impact of COVID-19 on Patients With Cancer	26
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer	25
Angiosarcoma of the Breast	23
Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer	23
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer	22
Racial and Geographic Disparities in Endocrine Therapy Adherence Among Younger Breast Cancer Survivors	21
Vaccination and Immune Checkpoint Inhibitors	19
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment	19
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer	19
ACR–ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy	18
Medical Cannabis in Cancer Patients	17
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer	16
Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer	15
Trends in Diagnosis and Treatment of Metastatic Cancer in the United States	15
Breast and Cervical Cancer Screening Disparities in Transgender People	14
Effectiveness and Safety of Reirradiation With Stereotactic Ablative Radiotherapy of Lung Cancer After a First Course of Thoracic Radiation	14
Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors	13
ACR–ASTRO Practice Parameter for Image-guided Radiation Therapy (IGRT)	13
A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer	12
Social Determinants of Health in Oncology	12
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases	11
Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy	10

Characterizing Urban-Rural Differences in Colon Cancer Outcomes	10
Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma	10
Population-based Treatment Patterns and Outcomes for Stage III Non–Small Cell Lung Cancer Patients	10
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO)	9
Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer	9
Cost-effectiveness Analysis of Ado-trastuzumab Emtansine (T-DM1) for the Adjuvant Treatment of Patients With Residual Invasive HER2+ Early Breast Cancer in the United States	9
Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer	9
Management Strategies for Patients With Epithelioid Hemangioendothelioma	8
Food Intake During Cancer Therapy	8
Cancer Management During the COVID-19 Pandemic in the United States	8
Lower Levels of Trust in the Medical Profession Among White, Younger, and More-educated Individuals With Cancer	8
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors	8
Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone Metastases	8
Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors	8
Gender Differences in Outcomes of Patients With Mesothelioma	8
Clinical Trials Before, During, and After COVID-19 Pandemic	7
The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center	7
Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma	7
Systematic Review of Treatments for Colorectal Metastases in Elderly Patients to Guide Surveillance Cessation Following Hepatic Resection for Colorectal Liver Metastases	7
Concurrent β-blocker Use is Associated With Improved Outcome in Esophageal Cancer Patients Who Undergo Chemoradiation	7
Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma	7
Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC)	7
Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer	7
Stereotactic Body Radiotherapy and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer	7
Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer	7
Disparities in Surgical Recommendation for Stage I Non–Small Cell Lung Cancer	7
Interventions to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia	7
Proton Pump Inhibitors and Cancer Risk	6
Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking	6
Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections	6
Tumor Necrotic Debris and High Nuclear Grade	6
Tyrosine Kinase Inhibitors and the Relationship With Adherence, Costs, and Health Care Utilization in Commercially Insured Patients With Newly Diagnosed Chronic Myeloid Leukemia	6
Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma	6
Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer	6
Survivors’ Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation	6
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma	6
Prior Treatment for Non–small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy	6
A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer	6
“Was It Worth It?”	6
Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases	6
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy	6
Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers	5
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens	5
Journey to Diversity in a University Radiation Oncology Residency Program	5
Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma	5
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer	5
Sepsis Hospitalizations With Versus Without Cancer	5
Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients	5
Community-based Cancer Care Quality and Expertise in a COVID-19 Era and Beyond	5
Recent Trends and Overall Survival of Young Versus Older Adults With Stage II to III Rectal Cancer Treated With and Without Surgery in the United States, 2010-2015	5

Comparison of Radiation Treatment Volumes for Borderline Resectable Pancreatic Cancer in Contemporary Clinical Trials	5
Diagnostic Values of 8 Different Imaging Modalities for Preoperative Detection of Axillary Lymph Node Metastasis of Breast Cancer	5
Expansion of the LabBM Score	5
Incidental Coronary Artery Calcium on Breast Radiation Therapy Planning Scans Identifies Patients for Cardiac Preventive Therapy	5
Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database	5
Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy	5
Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer	5
Exercise Protocol With Limited Shoulder Range of Motion for 15 or 30 Days After Conservative Surgery for Breast Cancer With Oncoplastic Technique	4
Rectosigmoid Cancer—Rectal Cancer or Sigmoid Cancer?	4
Does the Interval Between Hysterectomy and Start of Adjuvant Radiation Treatment Influence Survival in Women With Endometrial Carcinoma?	4
Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer	4
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 2015	4
Benefits of a Multidisciplinary Women’s Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy	4
Radiotherapy in Early-stage Gastric MALT	4
Clinical Uncertainty and Equipoise in the Management of Recurrent Glioblastoma	4
Temporal Trends and Predictors of Opioid Use Among Older Patients With Cancer	4
Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder	4
Concurrent Nab-paclitaxel and Radiotherapy	4
Prospective Longitudinal Assessment of Health-related Quality of Life in Patients With Brain Metastases Undergoing Radiation Therapy	4
The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies	4
Stage-specific Conditional Survival Among Young (Age Below 50 y) Versus Older (Age 50 y and Above) Adults With Colorectal Cancer in the United States	4
False-positive 1p/19q Testing Results in Gliomas	4
ACR–ASTRO Practice Parameter for Communication	4
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study)	4
Do Patients With Multiple Myeloma Enrolled in Clinical Trials Live Longer?	4
Use of “Repurposed” Drugs in the Treatment of Epithelial Ovarian Cancer	4
A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast	4
Brain Radiation Induced Extracranial Abscopal Effects in Metastatic Melanoma	4
Prognostic Value of Preoperative Imaging	4
Regional Variation in Access to Oncologic Care and Racial Disparities Among Cervical Cancer Patients	4
Adjuvant FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Pancreatic Cancer	4
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer	4